Aktywne placebo. Dla tych którzy wierzą, że quetiapina, melatonina itp. działają nasennie...

Proponuję posłuchać: https://www.youtube.com/watch?v=-6xU5Grt4Mw Można też pogooglać, bo autor podaje wiele ciekawych tytułów: https://nowe.konsylium24.pl/k24/fora-dyskusyjne/po-dyzurze/lista/158 Znanym przykładem innego fejk 'leku' z antydepresantów jest mirtazapina o której "działaniu" powstało szereg publikacji: References 1. Kelder, J., et al., A comparison of the physicochemical and biological properties of mirtazapine and mianserin. J Pharm Pharmacol, 1997. 49(4): p. 403-11. 2. Gillman, P.K., Extracting value from case reports: lessons from Serotonin toxicity.Anaesthesia, 2006. 61: p. 419-422. 3. Gillman, P.K., Disease mongering: one of the hidden consequences. Public Library of Science: Medicine, 2006. 3(7): p. e316. DOI: 10.1371/journal.pmed.0030316. 4. Gillman, P.K., Pharmaceutical company influence. Public Library of Science: Medicine, 2006. 2(12): p. e392 http://medicine.plosjournals.org/perlserv/?request=read-response&doi=10.1371/journal.pmed.0020392#r1068. 5. Naunton, M. and K. Gillman, Pharmacy students and ‘Big Pharma’. Australian Pharmacist, 2006. 25: p. 562-583. 6. Smith, R.L., Medical Journals Are an Extension of the Marketing Arm of Pharmaceutical Companies. Public Library of Science: Medicine, 2005. 2: p. e138. 7. Horton, R., The dawn of McScience. New York Review of Books, 2004. 51: p. 7-9. 8. Angell, M., The truth about drug companies: How they deceive us and what to do about it.New York: Random House, 2005: p. 336. 9. Papanikolaou, G.N., et al., Reporting of conflicts of interest in guidelines of preventive and therapeutic interventions. BMC Med Res Methodol, 2001. 1: p. 3. 10. Als-Nielsen, B., et al., Association of funding and conclusions in randomized drug trials: a reflection of treatment effect or adverse events? Jama, 2003. 290(7): p. 921-8. 11. Chan, A.W., et al., Empirical evidence for selective reporting of outcomes in randomized trials: comparison of protocols to published articles. Jama, 2004. 291(20): p. 2457-65. 12. Taylor, R. and J. Giles, Cash interests taint drug advice. Nature, 2005. 437(7062): p. 1070-1. 13. Martinson, B.C., M.S. Anderson, and R. de Vries, Scientists behaving badly. Nature, 2005. 435(7043): p. 737-8. 14. Huston, P. and D. Moher, Redundancy, disaggregation, and the integrity of medical research. Lancet, 1996. 347(9007): p. 1024-6. 15. Tramer, M.R., et al., Impact of covert duplicate publication on meta-analysis: a case study. British Medical Journal, 1997. 315(7109): p. 635-40. 16. Ioannidis, J.P., Why most published research findings are false. Public Library of Science: Medicine, 2005. 2(8):